Takeda (Japan) Drug Class: Small molecule Mechanism/Technology: Pioglitazone is an FDA-approved drug for diabetes, which has also shown protective effects in brains of RRMS patients (Relapse-Remitting MS). It reduced production of cytokines & reactive oxygen species in cultured neurons. Primary Indication: Multiple Sclerosis Stage: Preclinical
